Andrew Mears’ Post

Outsourcing #patientrecruitment is an affordable, manageable way to make sure your trial isn't delayed and you keep within budget. In fact, 80% of clinical trials are delayed because they can't find enough eligible patients. The industry trend seems to be moving toward outsourcing for the specific skills and services that lie outside of a company's core competencies - which I support. Very often CROs and sponsor companies call nRollmed in what I call "rescue mode". They need eligible patients and they need them FAST to avoid the delays and expenses that could have been avoided if they had only considered #outsourcing earlier. I tell them there's no shame in outsourcing 😎 Looking forward to hearing what the panelists have to say about outsourcing partnerships.

What's your outsourcing strategy? Call HeartcoR today to talk about how we can help ensure your trials are completed on time and within budget. #CoreLab #ClinicalTrials #CardiacSafety https://loom.ly/dIIJWOQ

Check out this recent blog that explores the advantages of utilizing global resources across time zones within #FSP engagements, which enhances the efficiency of #clinicaldevelopment operations. » https://bit.ly/3vMscPE

A staggering 52% of credentialing departments still rely on entirely manual workflows 😱 𝐓𝐡𝐞 𝐧𝐞𝐞𝐝 𝐟𝐨𝐫 𝐚 𝐬𝐭𝐫𝐞𝐚𝐦𝐥𝐢𝐧𝐞𝐝, 𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐭 𝐜𝐫𝐞𝐝𝐞𝐧𝐭𝐢𝐚𝐥𝐢𝐧𝐠 𝐚𝐩𝐩𝐫𝐨𝐚𝐜𝐡 𝐡𝐚𝐬 𝐧𝐞𝐯𝐞𝐫 𝐛𝐞𝐞𝐧 𝐦𝐨𝐫𝐞 𝐜𝐫𝐢𝐭𝐢𝐜𝐚𝐥. Here’s what to consider when evaluating your current system or looking for a new solution: 🔹 Speed and Certification How quickly does your credentialing system verify files? It's vital to assess these claims closely to understand the actual capabilities and limitations of the system. 🔹 Quality Assurance Processes Robust QA processes are essential. They not only ensure the accuracy of credential verifications but also reflect your organization's commitment to compliance and provider satisfaction. 🔹 Future-Readiness How often is the platform updated, and what investments are made in enhancing user experience? Understanding the product's roadmap can shed light on its adaptability and future-proofing. 🔹 Setup and Implementation Complexity The ease of implementation and the time it takes to become fully operational are crucial. These factors determine how quickly you can benefit from the solution and its long-term viability. At Credsy, we blend rapid processing with meticulous quality checks, ensuring that every step of the credentialing process is not only fast but accurate and compliant with industry standards. We offer more than a quick fix; we provide a comprehensive solution that supports the credentialing lifecycle throughout your organization’s growth. 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐬𝐞𝐞𝐢𝐧𝐠 𝐨𝐮𝐫 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐢𝐧 𝐚𝐜𝐭𝐢𝐨𝐧? 🌟 Reach out to book a demo today and see how we can transform your credentialing process, reduce burnout, and enhance efficiency across the board. #HealthcareManagement #MedicalCredentialing #HealthTech #InnovationInHealthcare #HealthcareSolutions #EfficiencyInHealthcare #NCQA #CredentialingExcellence #HealthcareLeaders #StreamlineHealthcare

👩⚕️ 𝐂𝐫𝐞𝐝𝐞𝐧𝐭𝐢𝐚𝐥𝐢𝐧𝐠 is essential for medical professionals to access academic and medical institutions. However, it can be time-consuming and expensive for small 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬. Hiring vendors may be challenging, and managing the process requires the involvement of multiple departments. Businesses must allocate adequate resources for a smooth and efficient credentialing process. ➡️ If you are interested in learning more about how SVA can help with this process, please visit: https://hubs.li/Q02m5mlj0 #SVA #SVALS #LifeSciences #LifeSciencesIndustry

Check out #HealthLeaders 3 best practices for RCM partnerships. At #Fuse, we take pride in getting to know our customers, their workflows, and coding practices through our Clinical Consulting Team. By building #communication and #trust, our rule sets get stronger, leading to increased charge capture accuracy and more uncovered revenues. Join the conversation with our team today!#radonc #fuseonc

With increasing pressure on sponsors to optimize clinical trial delivery, our forthcoming webinar will explore the evolution of outsourcing strategies, with a focus on diverse FSP models. Register now to learn how the industry approach to FSP is shifting – and its impact on development costs and timelines. https://bit.ly/3RBRdWE #clinicalfsp #outsourcing

Forbes' article from earlier this week states 2023 has experienced over 115 pharma companies announcing layoffs and the Inflation Reduction Act's (IRA) impact hasn't even been fully felt yet. It ends with a chilling note: 💠 "IRA’s provisions will have profound implications for the industry’s future by reducing investments in life-saving drug R&D, slowing economic growth and diminishing overall health care quality for U.S. patients. Unfortunately, the worst may still be to come." 💠 As our CEO, Alana Goodman 🌸, noted in one of her recent articles "Is the Promising Pathways Act Really Promising? (linked below) || "...Which brings us full circle back to why the PPA isn't ideal and the IRA, which might reduce costs to patients, will not inspire innovation in industry, which could ultimately hinder any of the intended success of the Promising Pathways Act." Eerily similar thinking. What do YOU think? Is pharma/biotech feeling the squeeze a little harder than others in preparation for something bigger, like the IRA? Or is this just the beginning of any other <anticipated> recession? ✴ Link to Alana's Article: https://lnkd.in/efr3kPZR ✴ Link to Forbes Article: https://lnkd.in/e-Y6ps5t

"With MedixFlex, you can lean on certified #Epic analysts and support staff on a subscription basis, augmenting your workforce to align with support initiatives...On average, you can expect to save approximately 25% compared to typical consulting models." Learn more about the future of #Epic #EHR #staffing support here. https://hubs.li/Q028-dJL0

The Crucial Difference Between EMS and RAP (RIMS) in Regulatory Compliance **Recently, I had an insightful conversation with a leading consultant in the UK who specializes in advising regulatory boards. This discussion highlighted a critical distinction in our field: understanding the difference between an Engagement Management Solution (EMS) and a Regulatory Assurance Platform (RAP), also known as a Regulatory Information Management System (RIMS). The key lies in their approach to compliance. - Key Distinction: Compliance Centricity - EMS: Versatile but Often Lacks Regulatory Depth **Solutions starting with "I" are typically known as EMS, serving a broad range of organizations but often missing vital components for strict regulatory compliance. - RAP/RIMS: Designed for Regulatory Bodies In contrast, RAP focuses explicitly on meeting the unique legislative and regulatory demands, essential for entities recently empowered with regulatory authority. -Challenges with Traditional EMS Solutions: Organizations, even those advised by seasoned consultants, sometimes opt for EMS solutions that appear sufficient initially but later reveal significant gaps in regulatory functionality, leading to increased technical debt. ** Thentia Cloud: A Tailored RAP/RIMS Solution As a contrast, Thentia Cloud, specifically addresses these regulatory needs. Our platform is engineered to ensure regulatory compliance and public safety. - If your association has recently gained regulatory responsibilities, it's imperative to reassess whether your current EMS can support these new requirements. Join me for a demo and I'll show you the difference. https://thentia.com/demo/ #RegulatoryCompliance #ThentiaCloud #RIMS #EMSvsRAP #DigitalTransformation Amanda Prescia Micah Posey Natasha Persad